Serum Biomarkers in Lung Cancer

This study discusses four serum proteins: carcinoembryonic antigen, retinol binding protein, alpha1-antitrypsin, and squamous cell carcinoma antigen, and how they were collectively found to correctly classify the majority of lung cancer and control patients in the training set.

References and Resources
Patz E, Campa M, Gottlin E, et al. Panel of Serum Biomarkers for the Diagnosis of Lung Cancer. Journal of Clinical Oncology. 2007 Dec. Vol 25; Number 35.

Click Here to view abstract.

The Use of Virtual Reality for Pre-Procedural Planning and Practicing

Internal Medicine

Erik F. Wang, James Yu, DO, MS, John E. Rubin, MD, and Rohan Jotwani, MD, of the Department of Anesthesiology, Weill Cornell Medicine/New York-Presbyterian, New York, NY, describe the use...

► 1:04:07

The Reliability and Transferability of Current Randomized Controlled Trials Based on Real-World Evidence

Dermatology

Robert Kirsner, MD, PhD, University of Miami, Florida; Oscar M. Alvarez, PhD, Rutgers New Jersey Medical School, Newark, New Jersey; Vickie R. Driver, DPM, MS, INOVA Health System, Alexandria, Virginia;...

►

Physician Burnout: Addressing the Rapid Increase

Business of Medicine

Todd Unger, chief experience officer, AMA, and Christine Sinsky, MD, the AMA's vice president of professional satisfaction, discuss a recent study on physician burnout. Dr Sinsky explained that physician burnout...

► 13:25

An Overview of Research Program for Pompe Disease

Pompe Disease Content Hub

Priya Kishnani, MD, Chen Family Professor of Pediatrics, Chief of the Division of Medical Genetics, Duke University Medical Center, and Medical Director of the YT and Alice Chen Pediatric Genetic...

The Internal Medicine Channel